|
Kanavets N.S., Rebrova D.V.
Clinical cases of management of patients with type 2 diabetes mellitus using GLP-1 receptor agonists
|
№8 / 2024
|
|
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Romashkina L.P., Golubeva Yu.V.
Efficacy and safety of the russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
|
№8 / 2024
|
|
Semikova G.V., Volkova A.R., Khalimov Y.Sh., Ergert A.V., Timoschenko E.A.
Treatment of weight regain in obese patients after bariatric surgery
|
№4 / 2024
|
|
Antsiferov M.B., Antsiferova D.M., Koteshkova O.M., Demidov N.A.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
|
№2 / 2024
|
|
M.B. Antsiferov (1), A.V. Zilov (2), O.M. Koteshkova (1), N.A. Demidov (3)
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
|
№4 / 2021
|
|
E.G. Starostina
New era of type 2 diabetes mellitus therapy: cardiological indications for the use of glucagon-like peptide-1 receptor agonists
|
№4 / 2019
|
|
M.B. Antsiferov (1), V.V. Fadeev (2), T.B. Morgunova (2)
MODERN APPROACHES TO THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№16 / 2016
|
|
O.M. Koteshkova, L.P. Molina
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
|
№5 / 2016
|
|
I.Yu.Demidova
The Clinical Advantages Of The First Human Glp-1 Analogue Liraglutide In The Treatment Of Patients With Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
N.A. Petunina
Treatment Of Patients With Type 2 Diabetes Mellitus: Problems And Ways Of Their Solution
|
№17 / 2009
|
Русский
